Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 15, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 15, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 22, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 21, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 21, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 12, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 12, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 5, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 5, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 17, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 15, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 15, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 15, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 18, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 16, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 16, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 16, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 2, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2017 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 2, 2017 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 31, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 31, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 31, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 26, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 24, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 24, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 24, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 15, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 19, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 19, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 30, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 15, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 8, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 8, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 8, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 7, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 18, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 18, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 15, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 26, 2015 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 25, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders; drug delivery systems comprised of an implantable pump filled with pharmaceutical preparations for use in treating diabetes, obesity and metabolic diseases/disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Drug delivery systems, namely, an implantable pump; medical apparatus for the administration of pharmaceuticals in the nature of an implantable pump; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders in the nature of an incretin memetic pump
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Development and dissemination of printed and electronic educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; providing information in the fields of clinical trials of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, drug delivery technologies, and administration of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of capitalized three-dimensional letters "T2D" connected by a cylinder horizontally going through the middle of each letter and with the word "time" above the letter "T" and the word "disrupt" under the letter "D".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
TIME T TWO D DISRUPT; TIME T TO D DISRUPT
Classification
International Classes
005
010
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"T2D"